Creating and providing important tools for research on lymphatic filariasis.
Official title: PRODUCTION AND DISTRIBUTION OF FILARIAL RESEARCH REAGENTS DATA
Funded at University of Georgia · NIH-11308529 · Data updated 2026-11-12
This study is all about making important tools for labs in the U.S. that are working on finding better ways to treat and prevent lymphatic filariasis, a disease caused by parasitic worms, so that patients can eventually benefit from new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project start | March 1, 2025 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $1,392,486 |
| NIH project number | 75N93024D00035-0-759302500002-1 |
| Project ID | NIH-11308529 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals affected by lymphatic filariasis or those at risk of contracting the disease.
✕Less likely to help
Patients who do not have lymphatic filariasis or are not at risk for the disease may not receive any direct benefit from this research.
What this research studies
This research focuses on producing and supplying essential reagents that are crucial for laboratories in the U.S. that are investigating lymphatic filariasis, a disease caused by parasitic worms. By providing these reagents, the project aims to support the development of medical countermeasures to combat this condition. Patients may benefit indirectly as the research could lead to new treatments or preventive measures against lymphatic filariasis. The approach involves collaboration with various research institutions to ensure that the reagents meet the necessary standards for effective research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments or preventive measures for lymphatic filariasis, improving patient outcomes.
How similar studies have gone: Other research has shown success in developing medical countermeasures for parasitic diseases, indicating that this approach has potential.
Where this research is happening
-
University of Georgia
Athens, United States Active
Researchers
- Principal investigator: Gupta, Tuhina — University of Georgia
- Study coordinator: Gupta, Tuhina
Related research
Other NIH-funded projects on the same topics.
-
BRD4 and NIPBL work together to control facial bone development
A study in mice and cell models will explore how BRD4 and NIPBL work together to control how genes are turned on in facial development, which could clarify causes of craniofacial disorders.
-
Sulfated glycosaminoglycan hydrogels to protect brain volume after traumatic injury
A new implantable gel made from specially sulfated sugars may help prevent brain shrinkage and improve function after a serious brain injury.
-
Understanding how Kaposi’s sarcoma virus switches on late genes during infection
Scientists are studying how the virus causing Kaposi’s sarcoma turns on late genes when its DNA copies itself, which could reveal new ways to treat cancer in people with AIDS.
-
Understanding how cells control signals and adhesion with the secretory pathway
A funded NIH project looks at how the cell’s secretory system shapes signals, receptors, and attachment to the outside of the cell, which can influence many human diseases.
-
AI-powered math and machine learning for bioscience and drug discovery
A broad NIH grant supports using advanced math and AI to better predict viral variants and aid drug discovery, with the goal of helping patients by accelerating pandemic response.
-
AI-driven platform to predict vaccine-escape variants and design mutation-proof antibodies
An AI-powered approach aims to anticipate SARS-CoV-2 variants that may dodge vaccines and to create antibodies that stay effective.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.